- Advertisement -
- Depression among people with diabetes remains a key health area to address.
- There has been recent interest in whether glucagon-like peptide-1 receptor agonists (GLP-1RAs) affect depression risk.
- One recent study found that GLP-1RAs may help lower the risk for depression compared to another medication for diabetes treatment, dipeptidyl peptidase-4…

